These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
243 related items for PubMed ID: 9230194
1. Infant acute leukemias show the same biased distribution of ALL1 gene breaks as topoisomerase II related secondary acute leukemias. Cimino G, Rapanotti MC, Biondi A, Elia L, Lo Coco F, Price C, Rossi V, Rivolta A, Canaani E, Croce CM, Mandelli F, Greaves M. Cancer Res; 1997 Jul 15; 57(14):2879-83. PubMed ID: 9230194 [Abstract] [Full Text] [Related]
2. Distribution of 11q23 breakpoints within the MLL breakpoint cluster region in de novo acute leukemia and in treatment-related acute myeloid leukemia: correlation with scaffold attachment regions and topoisomerase II consensus binding sites. Broeker PL, Super HG, Thirman MJ, Pomykala H, Yonebayashi Y, Tanabe S, Zeleznik-Le N, Rowley JD. Blood; 1996 Mar 01; 87(5):1912-22. PubMed ID: 8634439 [Abstract] [Full Text] [Related]
6. An in vivo topoisomerase II cleavage site and a DNase I hypersensitive site colocalize near exon 9 in the MLL breakpoint cluster region. Strissel PL, Strick R, Rowley JD, Zeleznik-Le NJ. Blood; 1998 Nov 15; 92(10):3793-803. PubMed ID: 9808573 [Abstract] [Full Text] [Related]
7. MLL genomic breakpoint distribution within the breakpoint cluster region in de novo leukemia in children. Felix CA, Hosler MR, Slater DJ, Parker RI, Masterson M, Whitlock JA, Rebbeck TR, Nowell PC, Lange BJ. J Pediatr Hematol Oncol; 1998 Nov 15; 20(4):299-308. PubMed ID: 9703001 [Abstract] [Full Text] [Related]
8. ALL-1 gene rearrangements in DNA topoisomerase II inhibitor-related leukemia in children. Felix CA, Hosler MR, Winick NJ, Masterson M, Wilson AE, Lange BJ. Blood; 1995 Jun 01; 85(11):3250-6. PubMed ID: 7756657 [Abstract] [Full Text] [Related]
9. Rearrangements involving chromosome band 11Q23 in acute leukaemia. Rowley JD. Semin Cancer Biol; 1993 Dec 01; 4(6):377-85. PubMed ID: 8142623 [Abstract] [Full Text] [Related]
13. Panhandle PCR strategy to amplify MLL genomic breakpoints in treatment-related leukemias. Megonigal MD, Rappaport EF, Jones DH, Kim CS, Nowell PC, Lange BJ, Felix CA. Proc Natl Acad Sci U S A; 1997 Oct 14; 94(21):11583-8. PubMed ID: 9326653 [Abstract] [Full Text] [Related]
14. Transplacental chemical exposure and risk of infant leukemia with MLL gene fusion. Alexander FE, Patheal SL, Biondi A, Brandalise S, Cabrera ME, Chan LC, Chen Z, Cimino G, Cordoba JC, Gu LJ, Hussein H, Ishii E, Kamel AM, Labra S, Magalhães IQ, Mizutani S, Petridou E, de Oliveira MP, Yuen P, Wiemels JL, Greaves MF. Cancer Res; 2001 Mar 15; 61(6):2542-6. PubMed ID: 11289128 [Abstract] [Full Text] [Related]
16. In vitro cleavage of the MLL gene by topoisomerase II inhibitor (etoposide) in normal cord and peripheral blood mononuclear cells. Ishii E, Eguchi M, Eguchi-Ishimae M, Yoshida N, Oda M, Zaitsu M, Fujita I, Miyazaki S, Hamasaki Y, Mizutani S. Int J Hematol; 2002 Jul 15; 76(1):74-9. PubMed ID: 12138900 [Abstract] [Full Text] [Related]